Cytopenia Study Seeks Volunteers

The road to recovery after a bone marrow transplant can be complicated by cytopenia(s) (when one or more of your blood cell types is lower than normal). Sometimes, this is “immune-mediated,” meaning your red cells or platelets are being targeted and destroyed by the body’s immune system. NHLBI researchers are testing the drug fostamatinib in adults with immune-mediated cytopenia(s) to see whether it will help. The study enrolls adults who are ≥ 60 days post-transplant, experiencing hard-to-treat cytopenia(s) and are transfusion dependent. If you know someone that qualifies, contact the Office of Patient Recruitment at (866) 444-2214 (TTY users dial 711), ccopr@nih.gov. Ask for study #000758-H. Online: https://bit.ly/3Vh6ZUP.